Picture of Bioscience Neutraceuticals logo

DEVV Bioscience Neutraceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro Cap

Annual cashflow statement for Bioscience Neutraceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2015
December 31st
C2016
December 31st
2017
December 31st
2018
December 31st
2019
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.048-0.011-0.15-0.074-0.626
Non-Cash Items00.1090.0040.559
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.0050.005-0.0010.0220.03
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.043-0.006-0.042-0.047-0.037
Other Investing Cash Flow Items00-0.048-0.0010
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities00-0.048-0.0010
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities00.0040.0910.0470.037
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.043-0.0020.001-0.0010

Or unlock with your email

Or unlock with your email